Assessing Drug Administration Techniques in Zebrafish Models of Neurological Disease

dc.contributor.authorChaoul, Victoria
dc.contributor.authorDib, Emanuel Youssef
dc.contributor.authorBedran, Joe
dc.contributor.authorKhoury, Chakib
dc.contributor.authorShmoury, Omar
dc.contributor.authorHarb, Frédéric F.
dc.contributor.authorSoueid, Jihane
dc.contributor.departmentBiochemistry and Molecular Genetics
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:38:30Z
dc.date.available2025-01-24T11:38:30Z
dc.date.issued2023
dc.description.abstractNeurological diseases, including neurodegenerative and neurodevelopmental disorders, affect nearly one in six of the world’s population. The burden of the resulting deaths and disability is set to rise during the next few decades as a consequence of an aging population. To address this, zebrafish have become increasingly prominent as a model for studying human neurological diseases and exploring potential therapies. Zebrafish offer numerous benefits, such as genetic homology and brain similarities, complementing traditional mammalian models and serving as a valuable tool for genetic screening and drug discovery. In this comprehensive review, we highlight various drug delivery techniques and systems employed for therapeutic interventions of neurological diseases in zebrafish, and evaluate their suitability. We also discuss the challenges encountered during this process and present potential advancements in innovative techniques. © 2023 by the authors.
dc.identifier.doihttps://doi.org/10.3390/ijms241914898
dc.identifier.eid2-s2.0-85174717062
dc.identifier.pmid37834345
dc.identifier.urihttp://hdl.handle.net/10938/29069
dc.language.isoen
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)
dc.relation.ispartofInternational Journal of Molecular Sciences
dc.sourceScopus
dc.subjectAlzheimer’s disease
dc.subjectAutism spectrum disorders
dc.subjectDrug delivery systems
dc.subjectHuman neurological disease modeling
dc.subjectParkinson’s disease
dc.subjectTraumatic brain injury
dc.subjectZebrafish
dc.subjectAged
dc.subjectAnimals
dc.subjectBrain
dc.subjectDisease models, animal
dc.subjectHumans
dc.subjectMammals
dc.subjectNervous system diseases
dc.subjectNeurodevelopmental disorders
dc.subjectHydrogel
dc.subjectNanoparticle
dc.subjectAlzheimer disease
dc.subjectAmyotrophic lateral sclerosis
dc.subjectAutism
dc.subjectCerebrovascular accident
dc.subjectDrug delivery system
dc.subjectGenetic manipulation
dc.subjectGenetic screening
dc.subjectMicroinjection
dc.subjectNeurologic disease
dc.subjectNonhuman
dc.subjectOral drug administration
dc.subjectParkinson disease
dc.subjectReview
dc.subjectWater immersion
dc.subjectZebra fish
dc.subjectAnimal
dc.subjectDisease model
dc.subjectGenetics
dc.subjectHuman
dc.subjectMammal
dc.subjectMental disease
dc.titleAssessing Drug Administration Techniques in Zebrafish Models of Neurological Disease
dc.typeReview

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2023-415.pdf
Size:
1.05 MB
Format:
Adobe Portable Document Format